一份病例报告描述了心肌缺血作为卡巴马西过量服用的副作用
Małgorzata M Skiba1, Mateusz Szymański1,2, Małgorzata Piasecka1
1Intensive Care Unit, Stefan Cardinal Wyszyński District Specialist Hospital, Al. Kraśnicka 100, Lublin 20-718, Poland.
European heart journal. Case reports
|September 30, 2024
概括
过量服用卡巴马西平可能会导致冠状动脉,这是一种罕见但严重的副作用,未在药物信息中列出. 及时诊断和用酸甘治疗对于患者的康复至关重要.
科学领域:
- 心脏病学 心脏病学
- 临床毒理学 临床毒理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 过量服用卡巴马西平可以导致各种并发症.
- 冠状动脉是一个潜在的,虽然很少见的,卡巴马西平过量服用的不良影响.
- 标准药物信息可能没有列出冠心血管作为已知的副作用.
研究的目的:
- 报告卡巴马西平过量服用病例,出现冠状动脉血管.
- 强调在卡巴马西平过量服用时诊断冠状动脉的重要性,以有效管理.
- 强调及时心脏干预在改善患者治疗结果中的作用.
主要方法:
- 一个46岁的病人过量服用卡巴马西的病例报告.
- 重症监护病房管理,包括机械呼吸和心律失常的治疗.
- 紧急冠状动脉血管学诊断冠状动脉血管.
- 用酸甘油进行治疗干预.
主要成果:
- 患者出现了严重的并发症,包括意识变化,呼吸困难和耐火性心律失常.
- 冠状动脉扫描显示左侧环动脉有显著的.
- 酸甘油的使用成功地解决了冠状动脉血管.
- 血动力学稳定性得到了实现,患者的病情得到改善,导致出院.
结论:
- 冠状动脉应考虑在卡巴马西平过量服用并出现心脏症状的患者.
- 通过冠状动脉扫描进行早期诊断,并及时使用酸甘等血管扩展剂进行治疗至关重要.
- 这一案例强调了全面诊断评估在管理复杂药物过量场景中的重要性.
相关概念视频
Coronary Artery Disease III: Clinical Manifestations
3
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
3
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
462
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
462
Antiepileptic Drugs: Potassium Channel Activators
149
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
149
Anticholinesterase Agents: Poisoning and Treatment
808
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
808
Heart Failure Drugs: Inotropic Agents
535
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
535
Cardiomyopathy II: Dilated Cardiomyopathy
1
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
1


